» Articles » PMID: 20133346

Periodic Lateralized Epileptiform Discharges in Neuropsychiatric Lupus: Association with Cerebritis in Magnetic Resonance Imaging and Resolution After Intravenous Immunoglobulin

Overview
Journal Lupus
Publisher Sage Publications
Specialty Rheumatology
Date 2010 Feb 6
PMID 20133346
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

A 13-year-old girl with a known diagnosis of systemic lupus erythematosus presented with seizures and psychosis. An electroencephalogram (EEG) revealed continuous, non-evolving periodic lateralized epileptiform discharges (PLEDs) in the left temporal region, which did not resolve with benzodiazepine. A magnetic resonance imaging (MRI) brain scan demonstrated a focal hyperintensity in the left medial temporal and left occipital lobes, left thalamus and bilateral cerebellar white matter, with evidence of vasculitis in the magnetic resonance angiography. Intravenous immunoglobulin was given because of failed steroid therapy, which resulted in a full resolution of clinical, EEG and MRI abnormalities. Lupus cerebritis should be considered as a possible aetiology in PLEDs, and immunoglobulin can be effective in neuropsychiatric lupus.

Citing Articles

Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels.

Hansen K, Wollmuth L, Bowie D, Furukawa H, Menniti F, Sobolevsky A Pharmacol Rev. 2021; 73(4):298-487.

PMID: 34753794 PMC: 8626789. DOI: 10.1124/pharmrev.120.000131.


The diverse and complex modes of action of anti-NMDA receptor autoantibodies.

Wollmuth L, Chan K, Groc L Neuropharmacology. 2021; 194:108624.

PMID: 34081993 PMC: 8693782. DOI: 10.1016/j.neuropharm.2021.108624.


Periodic electroclinical seizures following an ischemic stroke revealed by continuous-EEG.

Elmali A, Ekizoglu E, Ciftci I, Yesilot N, Coban O, Baykan B Epilepsy Behav Rep. 2021; 15:100428.

PMID: 33665600 PMC: 7905351. DOI: 10.1016/j.ebr.2021.100428.


Indications for IVIG in rheumatic diseases.

Mulhearn B, Bruce I Rheumatology (Oxford). 2014; 54(3):383-91.

PMID: 25406359 PMC: 4334686. DOI: 10.1093/rheumatology/keu429.


Modulation of Immunity and the Inflammatory Response: A New Target for Treating Drug-resistant Epilepsy.

Yu N, Liu H, Di Q Curr Neuropharmacol. 2013; 11(1):114-27.

PMID: 23814544 PMC: 3580785. DOI: 10.2174/157015913804999540.